Quality of life in MAP.3 (Mammary Prevention 3): a randomized, placebo-controlled trial evaluating exemestane for prevention of breast cancer
published in: Journal of Clinical Oncology
date of publication: 2014-04-07
language: English
main subject: placebo, placebo-controlled trial
Cites articles 24
Date
Title
Article - wd:Q36934323